Use of selenium in the design of medical devices and anti-cancer, anti-microbial and anti-viral drugs
12:45pm - 1:45pm /
Friday 23rd September 2016
/ Venue: William Henry Duncan Building Apex Building
- 0151 794 9003
- Brenda Smith
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Dr. Ted Reid received his Bachelors in Chemistry from Occidental College and his Masters in Chemistry from the University of Arizona working in Natural Products Chemistry. He then received his Doctorate in Chemistry/Biochemistry from the University of California, Los Angeles, working on the mechanism of action of Pepsin. This was followed by postdoctoral studies with Irwin Wilson at the University of Colorado on the mechanism of action of alkaline phosphatase. He then moved to a faculty position at Yale University, for 14 years, in the Departments of Molecular Biophysics and Biochemistry and the Ophthalmology and Visual Science. His work at Yale was on ocular tumors and tumor viruses. In 1984 he joined the faculty of the University of California, Davis, where his laboratory worked on defense peptides and neuropeptides in ocular wound healing. In 1990 he moved to the Texas Tech University Health Sciences Center where he is the Director of the Biotechnology Program and Vice Chairman of Ophthalmology. His research currently concerns wound healing, drug design and the use of organo-selenium compounds to combat biofilms and bacterial infection.